Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen and cognitive functioning in women.

Barbara B Sherwin1

  • 1Department of Psychology, McGill University, Montreal, Quebec, Canada H3A 1B1. bsherwin@ego.psych.mcgill.ca

Endocrine Reviews
|April 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid hormones and cognitive functioning in healthy, euthyroid women: a correlational study.

Hormones and behavior·2012
Same author

Estrogen and cognitive functioning in women: lessons we have learned.

Behavioral neuroscience·2011
Same author

Hormones and cognitive functioning during late pregnancy and postpartum: a longitudinal study.

Behavioral neuroscience·2011
Same author

Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.

Fertility and sterility·2011
Same author

Sex steroid hormones and cognitive functioning in healthy, older men.

Hormones and behavior·2010
Same author

A randomized controlled trial of estrogen treatment in men with mild cognitive impairment.

Neurobiology of aging·2009

Estrogen replacement therapy (ERT) shows promise for protecting verbal memory in postmenopausal women and reducing Alzheimer's disease risk. However, ERT does not improve cognitive function in women already diagnosed with Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Cognitive Aging
  • Hormone Therapy

Background:

  • Basic neuroscience research supports estrogen replacement therapy (ERT) for cognitive aging protection in women.
  • Randomized trials indicate estrogen preferentially benefits verbal memory in postmenopausal women.
  • Observational studies suggest a broader cognitive effect of estrogen, with epidemiological data linking ERT to reduced Alzheimer's disease (AD) risk.

Purpose of the Study:

  • To evaluate the efficacy of estrogen replacement therapy (ERT) in protecting against cognitive aging and Alzheimer's disease (AD) in women.
  • To investigate the differential effects of ERT on cognitive functions, particularly verbal memory.
  • To explore the potential critical window for ERT intervention in the postmenopausal period.

Main Methods:

Related Experiment Videos

  • Review of evidence from randomized controlled trials (RCTs) of estrogen and cognition.
  • Analysis of findings from observational and epidemiological studies on ERT and cognitive function.
  • Examination of controlled treatment trials in women with probable AD.

Main Results:

  • RCTs demonstrate ERT's preferential protection of verbal memory in postmenopausal women.
  • Epidemiological studies consistently show ERT significantly reduces Alzheimer's disease (AD) risk.
  • Controlled trials in women with diagnosed AD failed to show ERT ameliorates existing deficits or prevents memory deterioration.

Conclusions:

  • Estrogen replacement therapy (ERT) may protect against cognitive decline and reduce AD risk, particularly when initiated in the early postmenopausal period.
  • The timing of ERT initiation appears critical for maximizing cognitive benefits and AD risk reduction.
  • ERT is not effective in treating established cognitive deficits or preventing further decline in women with diagnosed Alzheimer's disease.